AI risk assessments: Future-proofing your innovation when rules can change mid-game
At the Intersection of Science and Law
English - September 06, 2022 16:54 - 24 minutes - 22.7 MBLife Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The rise of telehealth amid the COVID-19 pandemic
Next Episode: Global Life Sciences Supply Chain Insights
Published in Chambers Expert Focus. DLA Piper partner Danny Tobey is joined by Aviva Wein, Assistant General Counsel at Johnson & Johnson, to discuss how medical device and pharmaceutical companies are future-proofing their innovations in artificial intelligence as new regulations and risks arise.
See omnystudio.com/listener for privacy information.